A carregar...

Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells

Triple negative breast cancer (TNBC) is an aggressive form of breast cancer which accounts for 15–20% of this disease and is currently treated with genotoxic chemotherapy. The BCL2 (B-cell lymphoma 2) family of proteins controls the process of mitochondrial outer membrane permeabilization (MOMP), wh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Lucantoni, Federico, Lindner, Andreas U., O’Donovan, Norma, Düssmann, Heiko, Prehn, Jochen H. M.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833806/
https://ncbi.nlm.nih.gov/pubmed/29352235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0039-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!